June 8, 2020 / 1:52 PM / a month ago

BRIEF-Teneobio Enters Licensing Agreement To Develop Next Generation Engineered Cell Therapies With Intellia

June 8 (Reuters) - Intellia Therapeutics Inc:

* TENEOBIO ENTERS A RESEARCH COLLABORATION AND LICENSING AGREEMENT TO DEVELOP NEXT GENERATION ENGINEERED CELL THERAPIES WITH INTELLIA THERAPEUTICS

* TENEOBIO INC - INTELLIA WILL HAVE OPTION TO EXCLUSIVELY LICENSE NOVEL ANTIBODIES FOR GLOBAL DEVELOPMENT, COMMERCIALIZATION

* TENEOBIO, INC - UNDER TERMS OF AGREEMENT, CO WILL RECEIVE UPFRONT PAYMENT

* TENEOBIO - UNDER AGREEMENT, CO TO BE ELIGIBLE TO GET ADDITIONAL PAYMENTS FOR SOME PRECLINICAL, CLINICAL, REGULATORY, COMMERCIAL MILESTONES’ ACHIEVEMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below